OTC Medicines

Browse OTC Medicines Content

Prior to the pandemic, the self-care sector was already expanding rapidly, with health spending increasing 31-fold per capita over the past four decades. IRI and CHPA recently released this report about how consumer self-care has specifically changed.

Jul 14, 2021

CHPA, in partnership with its members and state legislatures, takes decisive action to combat teen abuse of dextromethorphan.

Jul 1, 2021

Ohio Governor Mike DeWine signed into law HB 9, prohibiting the sale of DXM-containing products to minors.

Jul 1, 2021

CHPA awarded its Ivan D. Combe Lifetime Achievement Award Wednesday to longtime industry leader Scott Emerson.

Jun 18, 2021

Oregon has repealed a 15-year-old law that banned OTC sales of certain medicines for colds and allergies containing PSE.

Jun 17, 2021

The Consumer Healthcare Products Association (CHPA) today announced the election of Michelle Wang Goodridge as the new Chair of the CHPA Board of Directors. Goodridge was elected along with six new board members.

Jun 16, 2021

PCPC and CHPA appreciate the opportunity to comment on FDA Notice of Intent to Prepare and Environmental Impact Statement to evaluate environmental effects for marketing certain OTC sunscreen products.

Jun 14, 2021

In keeping with the mission of the FDA Center for Drug Evaluation and Research’s Office of Surveillance and Epidemiology Division of Medication Error and Prevention Analysis, this CHPA member feedback is designed to minimize the risk of medication errors due to consumer confusion attributed to an OTC drug product name.

Jun 14, 2021

Consumer self-care changed during the COVID-19 pandemic. This report from IRI and CHPA divides consumers into seven distinct segments and discussed how CPGs and retailers can reach them with the right health and wellness solutions.

Jun 10, 2021

Filter Results